Last year, I conducted a series of interviews with GPs in order to understand their experiences with anticoagulation management in patients with atrial fibrillation (AF). It is well known that AF is the most common arrhythmia seen in Australian general practice, and that the use of anticoagulants is a well-established intervention to reduce the risk of thromboembolism. This is reflected in the 2018 National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand AF guidelines.
As such, I wanted to know more about GPs’ experiences with anticoagulation, and any barriers they may have with initiating anticoagulation. Below is what I found out from the research study:
For more information, see the published paper
If you are interested in the latest clinical updates on AF, and multiple other general practice topics, join us in February for our signature CPD program, the 2022 version of Hot Topics GP Update course.
Eyob Gebreyohannes (PhD candidate at the University of Western Australia – Optimising anticoagulation in atrial fibrillation in Australian general practice setting.)
BPharm, MSc, Ph.D. Candidate
Division of Pharmacy • School of Allied Health
Faculty of Health and Medical Sciences, University of Western Australia
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreAn increasing number of pregnant patients are seeking advice from their GP about prenatal genetic testing. This FastTrack covers non-invasive prenatal testing/screening, including how it works, indications, limitations, and different types of testing panels. 30mins each of RP and EA CPD available.
Wearables with PPG or ECG capabilities can identify episodes of irregular heart rhythms suggestive of AF, but should not replace traditional methods of diagnosis, such as a 12-lead ECG. Evidence of accuracy and positive predictive values from prospective, comparative trials involving older populations are limited, and the potential for inconclusive results remains a concern based on current trial findings. Their utility may be highest for symptomatic individuals or those at risk of developing AF.
Reproductive genetic carrier screening (RGCS) may be considered for patients during their preconception counselling stage. This FastTrack covers who should be offered RGCS, which conditions it screens for, and what to do with the results. 30mins each of RP and EA CPD available.